Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Posts Narrowed Q3 Loss, Expects Profitability in 02

NEW YORK, Oct. 31 - Transgenomic reported a third-quarter net loss of 8 cents per share on top of revenues of $10.3 million, a 64 percent increase over the same period last year, and said it intends to become profitable by the end of 2002.

“The strength of our balance sheet, with $47 million in cash and investments, with no debt, gives us the resources needed to execute our plan to achieve profitability by the end of 2002,” CEO Collin D'Silva said in a statement.

Transgenomic, based in Omaha, Neb., reported a third-quarter net loss of $1.9 million, or $0.08 per share, compared with $2.0 million in the same period on year earlier.

The loss excludes goodwill associated with the company’s $4 million acquisition of Annovis , a San Diego-based nucleic acid and reagent maker. Including those charges, Transgenomic absorbed a net loss of $1.6 million, or 7 cents a share.

“Our focus remains in driving recurring revenue streams through the ongoing introduction of proprietary products in the areas of bioconsumables and synthetic nucleic acids,” D’Silva said.

Shares in Transgenomic closed up $1.05, or 11.5 percent, to $10.19 on the Nasdaq on Wednesday.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.